Propanc Biopharma 10K 2017 Annual report | PPCB Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: Amatsigroup, analyse, andin, appeal, aspect, athymic, authoritative, balloon, Baseline, Binomial, bioavailability, biopharma, book, Brexit, Cancerin, capillary, CDI, CellTracker, clarity, coefficient, conceivably, concert, conferred, Corrupt, CW, debate, digit, disappearance, dispersed, disproportionate, Distinguishing, Dossier, Eagle, emission, endothelial, endpoint, envisioned, euthanized, excised, explanation, extinguishment, extremely, faster, Fig, FIH, fluorescence, fluorescenct, fold, forma, gauge, green, GS, harmonize, host, Hummelstown, HUVEC, IIb, imaged, imaging, implicated, indirect, inflated, inoculated, intravenously, investigatedin, invoice, invoked, IRDye, IRS, junior, Lisbon, loaded, lt, machinery, marked, markedly, medicament, MIA, modulation, monolayer, multicenter, murine, notification, officially, orthotopically, orthotropically, ovary, overly, PA, page, paragraph, parallel, parent, Paymentissued, PBS, peak, performedin, plastic, PPCB, principle, prohibited, Proportional, punitive, quantification, quickly, referendum, refinanced, Regal, regimen, relocate, repeal, rescinded, round, running, samll, scratch, securitization, significantin, significantlylower, slight, Slug, spouse, staining, subdivision, subordinate, subordinated, substrate, subtopic, tail, tasked, Teflon, thein, theJournal, thirteen, transmigrate, tube, umbilical, unaffiliated, unconverted, unlabelled, unused, urging, variation, vimentin, vivoa, vivousing, waive, waiver, width

Removed: additive, adjunct, adriblastine, aerobic, aggregated, anaerobic, antagonistic, anticipation, Asia, augment, biochemical, biomarker, black, brokerage, BSM, cachexia, capsiate, capturing, carbohydrate, Chile, chymotrypsin, Circuit, Clayton, clearing, collectively, commitment, complaint, cytometry, damaging, DCM, derived, determinantof, distributed, divided, dosed, doxorubicin, dropped, Eastern, eating, element, employ, energy, enhancing, entry, EPO, esophageal, excellent, experiment, explored, facilitated, forty, freely, FvB, glucanohydrolase, glucose, grafted, growing, Hong, hunching, increment, India, inhibiting, interfering, jointly, kg, Kong, Leon, man, maximizing, measuredxnumber, metabolism, metabolite, methylselenocysteine, minimal, mitochondria, mL, mm, modern, moving, ng, nontoxic, nutrition, observe, optimize, optimizing, organelle, OTCBB, oxidative, oxygen, Paul, Peru, pioneering, planning, PPCH, preceding, preliminary, pronounced, proven, quantitate, quantity, randomly, rarely, region, Registrable, relation, reputation, respiration, Richmond, Russia, sacrificed, screen, sharply, significantlylowersurvival, singular, slightly, Sorafenib, splitting, stipulation, subcutaneously, substance, suited, sweet, synergise, synergism, therefrom, tolerated, Trust, ulcerating, unregistered, untreated, USPTO, vaccine, Vietnam, weakening, wet

Propanc Biopharma (PPCB) 10-K2017 FY Annual report

Content analysis